Aastrom up big in today's trading

|By:, SA News Editor

Shares of nano cap Aastrom Biosciences (ASTM +25.4%) roar ahead on a 12x surge in volume. Today's bullish action follows yesterday's 24% up move.

Market chatter says that the firm will report good news from its phase 2 clinical trial of ixmyelocel-T at the upcoming Regen Med Investor Day on March 26 in Ann Arbor, MI.

The company's market cap is only $25M. Average daily turnover is a modest 200K shares. Investors should be cautious here.